Association Between RFC1 G80A Polymorphism and Acute Lymphoblastic Leukemia: a Review and Meta-Analysis of 10 Studies
- PMID: 27222703
- PMCID: PMC4867172
Association Between RFC1 G80A Polymorphism and Acute Lymphoblastic Leukemia: a Review and Meta-Analysis of 10 Studies
Abstract
Background: Evidence indicates RFC1 G80A polymorphism as a risk factor for a number of cancers. Increasing studies have been conducted on the association of RFC1 G80A polymorphism with acute lymphoblastic leukemia (ALL) risk. However, the results were controversial. The aim of the present study was to derive a more precise estimation of the relationship.
Materials and method: PubMed, Embase, Web of Science, Cochrane database, and Google Scholar were searched to get the genetic association studies between RFC1 G80A polymorphism and ALL. All eligible studies for the period up to February 2016 were identified. Subgroup analyses regarding ethnicity were also implemented. All statistical analyses were done with CMA 2.0.
Results: A total of ten studies comprising of 2,168 ALL cases and 2,693 healthy controls were included in this meta-analysis. Overall, no significant association was detected for allelic model (OR = 1.029, 95 % CI 0.754- 1.405, P=0.000), Dominant model (OR = 1.619, 95 % CI 0.847-3.094, P=0.145), recessive model (OR = 1.169, 95 % CI 10.764-1.790, P=0.429), and homozygote model (OR = 1.288, 95 % CI 0.928-1.788, P=0.130). However, there was an obvious association under the heterozygote model (OR = 1.368, 95 % CI 1.056- 1.772, P=0.018). Also, in the stratified analysis by ethnicity, no significant association of this polymorphism with risk of OC was found in the Asian and Caucasian populations. However, there was not significant heterogeneity between heterozygote genetic model (P = 0.15, I(2) = 33%) in Caucasian. Therefore, we utilized the fixed-effect model to merge OR value.
Conclusion: Based on the available evidence, no association between RFC1 G80A Polymorphism and ALL risk was observed, even in the subanalysis by ethnicity. The direction of further research should focus not only on the simple relationship of RFC1 G80A Polymorphism and ALL risk, but also on gene-gene and gene-environment interaction.
Keywords: Acute lymphoblastic leukemia; G80A Polymorphism; Genetic polymorphism; Meta-analysis; RFC1.
Figures




Similar articles
-
The association between RFC1 G80A polymorphism and cancer susceptibility: Evidence from 33 studies.J Cancer. 2016 Jan 1;7(2):144-52. doi: 10.7150/jca.13303. eCollection 2016. J Cancer. 2016. PMID: 26819637 Free PMC article.
-
Association between reduced folate carrier G80A polymorphism and methotrexate toxicity in childhood acute lymphoblastic leukemia: a meta-analysis.Leuk Lymphoma. 2014 Dec;55(12):2793-800. doi: 10.3109/10428194.2014.898761. Epub 2014 Apr 3. Leuk Lymphoma. 2014. PMID: 24597986
-
Reduced folate carrier gene G80A polymorphism is associated with an increased risk of gastroesophageal cancers in a Chinese population.Eur J Cancer. 2006 Dec;42(18):3206-11. doi: 10.1016/j.ejca.2006.04.022. Epub 2006 Sep 8. Eur J Cancer. 2006. PMID: 16962770
-
Role of polymorphisms of GSTM1, GSTT1 and GSTP1 Ile105Val in childhood acute lymphoblastic leukemia risk: an updated meta-analysis.Minerva Pediatr. 2018 Apr;70(2):185-196. doi: 10.23736/S0026-4946.17.04657-6. Epub 2017 Feb 7. Minerva Pediatr. 2018. PMID: 28176509 Review.
-
Association of β2-adrenergic receptor gene polymorphisms (rs1042713, rs1042714, rs1042711) with asthma risk: a systematic review and updated meta-analysis.BMC Pulm Med. 2019 Nov 7;19(1):202. doi: 10.1186/s12890-019-0962-z. BMC Pulm Med. 2019. PMID: 31699066 Free PMC article.
Cited by
-
A comprehensive consolidation of data on the connection between CDKN2A polymorphisms and the susceptibility to childhood acute lymphoblastic leukemia.Hematol Transfus Cell Ther. 2024 Dec;46 Suppl 6(Suppl 6):S332-S345. doi: 10.1016/j.htct.2024.05.017. Epub 2024 Oct 8. Hematol Transfus Cell Ther. 2024. PMID: 39443269 Free PMC article. Review.
-
Association between high-dose methotrexate-induced toxicity and polymorphisms within methotrexate pathway genes in acute lymphoblastic leukemia.Front Pharmacol. 2022 Nov 30;13:1003812. doi: 10.3389/fphar.2022.1003812. eCollection 2022. Front Pharmacol. 2022. PMID: 36532750 Free PMC article. Review.
-
Association of microRNA Polymorphisms with Toxicities Induced by Methotrexate in Children with Acute Lymphoblastic Leukemia.Hematol Rep. 2023 Nov 20;15(4):634-650. doi: 10.3390/hematolrep15040065. Hematol Rep. 2023. PMID: 37987321 Free PMC article. Review.
-
The Concept of Folic Acid in Health and Disease.Molecules. 2021 Jun 18;26(12):3731. doi: 10.3390/molecules26123731. Molecules. 2021. PMID: 34207319 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources